Casp8 (human) recombinant protein 25 unités
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunités, and a small protease subunités. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunitéss. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq]
Garantie
Garantie 0 Mois
Description
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunités, and a small protease subunités. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunitéss. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq]
Caractéristiques
- Fournisseur
- FISHER SCIENTIFIC S.A.S.
- Marque
- ABNOVA
- Référence fabricant
- P4039
- Référence distributeur
- 16262020
- Vendu par
- 25 unités
- Quantité
- N/A
- Lieu de fabrication
- Taiwan
- Lieu de stockage
- France
- Délai de péremption à la date de livraison
- 12 mois
- Code à barre
- non
- Soumis à carboglace
- oui
- Libellé produit fabricant
- 25unités casp8 (human) recombinant protein
- Certification
- RUO
- Marquage CE DIV
- non
- Type de produit
- protéine
- Type de protéine
- oui
- Type d'antibiotique
- non
- Type d'enzyme
- non
- Température de conservation (°C)
- -80 °C
- Température de transport
- carboglace
- Dispositif stérile
- non
- Type d'acide nucléique extrait
- non
- Origine humaine
- non
- Sans composant animal
- non
- Matière dangereuse
- non
- Autres caractéristiques
- Abnova Human CASP8 (Q14790) Recombinant Protein, Format: Lyophilized, Formulation: Lyophilized, Host Species: Escherichia coli, Protein Tag: none, Quantity: 25 Units, Recombinant: Yes, Regulatory Status: RUO, Accession Number: Q14790, Biological Acti
- Classification REACH
- non
- Code douanier
- 38229000
- Nomenclature IFPEN
- NA.55
- Nomenclature Nacres
- NA.55
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA55
- Nomenclature CNRS
- NA55
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD10AOOO
- Reprise en cas d’erreur client
- non
- Domaine de recherche
- protéomique
- Type d'échantillon
- protéine
- Type d’application
- ELISA, Western-Blot
